A Case of Secondary Hypersomnia Associated with Amlodipine
PDF
Cite
Share
Request
Case Report
P: 16-18
March 2019

A Case of Secondary Hypersomnia Associated with Amlodipine

J Turk Sleep Med 2019;6(1):16-18
1. Sağlık Bilimleri Üniversitesi, Gülhane Eğitim ve Araştırma Hastanesi, Nöroloji Kliniği, Ankara, Türkiye
2. Sağlık Bilimleri Üniversitesi, Gülhane Eğitim ve Araştırma Hastanesi, Psikiyatri Kliniği, Ankara, Türkiye
No information available.
No information available
Received Date: 01.11.2018
Accepted Date: 13.01.2019
Publish Date: 21.03.2019
PDF
Cite
Share
Request

ABSTRACT

Excessive daytime sleepiness is a symptom which can caused serious problems in patients life and is widely common in general population. It may be occurred depending on drug use and medical conditions. Secondary reasons must be investigated before making the diagnosis of primary hypersomnia in patients with excessive daytime sleepiness. In this case report, a patient who was followed up with the diagnosis of idiopathic hypersomnia, but was diagnosed as hypersomnia associated with amlodipine use along with conditions that Obstructive Sleep Apnea syndrome and delayed sleep phase syndrome may cause excessive daytime sleepiness, was presented.

Keywords: Hypersomnia, amlodipine, drug side effect

References

1
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd edition. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2014.
2
Yetkin S Özgen F. Hipersomnili Hastanın Değerlendirilmesi. Türkiye Klinikleri Journal of Internal Medicine Sciences, Uyku ve Uyku Bozuklukları Özel Sayısı 2007;3:13-8.
3
Berkowski JA, Shelgikar AV. Disorders of Excessive Daytime Sleepiness Including Narcolepsy and Idiopathic Hypersomnia. Sleep Med Clin 2016;11:365-78.
4
Perez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10(Suppl 1):S112-S23.
5
Billiard M, Dauvilliers Y. Idiopathic Hypersomnia. Sleep Med Rev 2001;5:349-58.
6
Bulsara KG, Cassagnol M. Amlodipine. 2018 Aug 14. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK519508/
7
Mohan JC, Jain R, Chamle V, Bhargava A. Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide. J Clin Diagn Res 2015;9:OC10-3.
8
NORVASC (amlodipine besylate) [Highlights of Prescribing Information] Pfizer Labs; Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf [updated Revised: May 2011)
9
Elliott WJ, Bistrika EA. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opin Drug Saf 2018;17:207-16.
10
Van Gastel A. Drug-Induced Insomnia and Excessive Sleepiness. Sleep Med Clin 2018;13:147-59.
11
Trotti LM. Idiopathic Hypersomnia. Sleep Med Clin 2017;12:331-44.
12
Benbir Şenel G. Pathophysiology, signs and symptoms in snoring and obstructive sleep apnea syndrome. Turkiye Klinikleri Ear Nose and Throat- Special Topics 2018;(3):1-8.
13
Savrun Y, Demir AB, Sıvacı AÖ, Bora İ, Zarifoğlu M. Our Cases of Secondary Narcolepsy with Three Different Etiology: Review of the Literature. J Turk Sleep Med 2015;(3):72-6.
14
Koç G Akçay BD, Karadaş Ö, Yetkin S. A Case of Pleiosomnia Following Traumatic Brain Injury. J Turk Sleep Med 2017;4:90-4.
2024 ©️ Galenos Publishing House